Insights

Strategic Leadership Terumo Cardiovascular is led by President and CEO Robert DeRyke, who has been in position since 2017, indicating stable leadership that can foster ongoing product development and customer relationships in the cardiovascular sector.

Innovative Product Portfolio The company has a history of pioneering technology, such as the introduction of the first hollow fiber oxygenator in 1982, demonstrating a strong foundation for developing advanced cardiac and vascular devices that could meet evolving clinical needs.

Global Manufacturing Presence With manufacturing operations across the U.S., Europe, and Asia, Terumo CV has the capacity to support international sales and customize solutions for diverse healthcare markets, creating growth opportunities worldwide.

Market Positioning Operating within a competitive landscape that includes companies like Abiomed and LivaNova, Terumo CV’s focus on cardiopulmonary bypass and intraoperative monitoring positions it to target hospitals and surgical centers seeking specialized cardiovascular solutions.

Growth Potential With revenue estimates between $100 million and $250 million and a history of product innovation, there is significant scope for expanding sales through hospital partnerships and targeted clinical adoption in the cardiovascular device market.

Similar companies to Terumo Cardiovascular Group

Terumo Cardiovascular Group Tech Stack

Terumo Cardiovascular Group uses 8 technology products and services including AppNexus, Cloudflare, Informatica, and more. Explore Terumo Cardiovascular Group's tech stack below.

  • AppNexus
    Advertising
  • Cloudflare
    Content Management System
  • Informatica
    Enterprise
  • Fortinet
    Network Hardware
  • C#
    Programming Languages
  • Minitab
    Visualisation Software
  • SAP Extended Warehouse Management
    Warehouse Management
  • Max Mega Menu
    Widgets

Terumo Cardiovascular Group's Email Address Formats

Terumo Cardiovascular Group uses at least 1 format(s):
Terumo Cardiovascular Group Email FormatsExamplePercentage
FLast@terumocv.comJDoe@terumocv.com
50%
FLast@terumocv.comJDoe@terumocv.com
50%

Frequently Asked Questions

What is Terumo Cardiovascular Group's official website and social media links?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group's official website is terumocv.com and has social profiles on LinkedIn.

What is Terumo Cardiovascular Group's NAICS code?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Terumo Cardiovascular Group have currently?

Minus sign iconPlus sign icon
As of December 2025, Terumo Cardiovascular Group has approximately 1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer, Vp Medical Affairs: S. P.Vp Finance And Cfo: O. V. G.Vice President Strategic Initiatives & Epm: M. Y.. Explore Terumo Cardiovascular Group's employee directory with LeadIQ.

What industry does Terumo Cardiovascular Group belong to?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group operates in the Medical Equipment Manufacturing industry.

What technology does Terumo Cardiovascular Group use?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group's tech stack includes AppNexusCloudflareInformaticaFortinetC#MinitabSAP Extended Warehouse ManagementMax Mega Menu.

What is Terumo Cardiovascular Group's email format?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group's email format typically follows the pattern of FLast@terumocv.com. Find more Terumo Cardiovascular Group email formats with LeadIQ.

When was Terumo Cardiovascular Group founded?

Minus sign iconPlus sign icon
Terumo Cardiovascular Group was founded in 1999.

Terumo Cardiovascular Group

Medical Equipment ManufacturingMichigan, United States1001-5000 Employees

Terumo Cardiovascular manufactures and markets medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass and intra-operative monitoring. The company is headquartered in Ann Arbor, Michigan, with manufacturing operations in the U.S., Europe and Asia. It is one of several subsidiaries of Terumo Corporation of Japan that is focused exclusively on cardiovascular surgery specialties. 

Our parent company, Terumo Corporation, is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.

This is the official LinkedIn account of Terumo Cardiovascular in the U.S. It is intended for medical professionals and is not a substitute for medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this account are registered in, approved for sale in, or available for purchase in, all countries or regions where this account is accessible. We make no warranty as to the accuracy, up-to-datedness, utility, completeness or other qualities of the information contained herein. Reliance on any information provided herein is solely at your own risk. We are not responsible for, nor make any warranty or recommendation of, any third-party contents appearing on this account, including but not limited to, advertisement, recommendation, and comments.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1999
Employees
1001-5000

Section iconFunding & Financials

  • $100M$250M

    Terumo Cardiovascular Group's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Terumo Cardiovascular Group's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.